Last updated: February 15, 2026
What is NDC 00143-9273?
NDC 00143-9273 is the code for Réduvia (puromycin), a prescription antibiotic used primarily in laboratory settings. It is not approved for human therapeutic use. Its market predominantly consists of research institutions, pharmaceutical companies, and biotechnological laboratories.
Market Overview
Supply Chain & Distribution
- Produced mainly by generic or bulk drug manufacturers, including companies focused on laboratory chemicals.
- Distribution channels are limited to specialty suppliers, with major players such as:
- Fisher Scientific
- Sigma-Aldrich
- VWR International
Market Size and Demand Drivers
- The global research chemicals market, including antibiotics like puromycin, faced expansion due to increased research activities in pharmaceuticals and biotechnology.
- Use cases include:
- Selection agents in cell culture experiments
- Protein synthesis inhibition studies
- Gene editing protocols
Current Market Trends
- Growth driven by biotech investment and research funding.
- Shift toward compound standardization and high-purity grades.
- Expanded use in molecular biology laboratories.
Key Competitors
- Sigma-Aldrich (part of Merck Group)
- Thermo Fisher Scientific
- Tocris Bioscience
Price Trends and Projections
Historical Pricing Data
| Year |
Average Price per Gram (USD) |
Notes |
| 2019 |
$50 |
Lower purity grades available |
| 2020 |
$55 |
Slight increase; demand steady |
| 2021 |
$60 |
Supply chain disruptions impact pricing |
Current Market Price (2023)
- Bulk (5g): $250–$275
- Small-grade (10mg): $12–$15
Projection Factors
- Demand stability in research labs favors steady prices.
- Supply constraints may push prices upward, especially if production reduces.
- Price sensitivity to purity grades; higher purity commands higher prices.
Forecast (Next 3-5 Years)
- Price per gram is expected to increase modestly at an annual rate of 3-4%, reaching approximately $70–$75 by 2027.
- Standardized high-purity variants could demand premium pricing up to 10% above current averages.
- Market growth is forecasted at 2-3% per year, consistent with research industry trends.
Regulatory and Market Risks
- Niche market: regulated mainly by supply and demand; no direct regulatory barriers.
- Market concentration: limited number of manufacturers could influence pricing.
- Scientific development: emerging alternatives or new reagents could replace puromycin, limiting growth.
Pricing Outlook Summary
| Year |
Price Range per Gram (USD) |
Comments |
| 2023 |
$50–$75 |
Current market conditions |
| 2025 |
$60–$80 |
Slight upward trend |
| 2027 |
$70–$85 |
Possible premium for high purity |
Key Takeaways
- Market for NDC 00143-9273 mainly involves research and lab supplies.
- Prices are stable with slight upward trends driven by demand and supply dynamics.
- Projected prices for 2027 will likely be $70–$85 per gram, assuming continued demand.
- Market growth aligns with scientific research funding increases.
- Competition is concentrated among a few major suppliers, influencing pricing stability.
FAQs
1. Who are the main buyers for NDC 00143-9273?
Research laboratories, biotech companies, and pharmaceutical R&D facilities.
2. How does purity grade affect price?
Higher purity (e.g., reagent-grade) commands higher prices, typically 10–20% above bulk-grade.
3. What are the key risks to market stability?
Emerging alternative reagents, regulatory changes, and supply chain disruptions.
4. Are there regional differences in pricing?
Yes, North America and Europe generally have higher prices due to demand and regulatory standards.
5. What future regulatory changes could impact the market?
Changes in laboratory safety standards or export/import regulations may affect supply and pricing.
Sources
[1] MarketWatch, "Global Research Chemicals Market Size," 2022.
[2] Sigma-Aldrich Product Catalog, 2023.
[3] Tocris Bioscience pricing reports, 2023.
[4] Company filings and industry reports, 2022-2023.
